|
[KSIC 1] |
July 3(Fri.) 14:30-16:00 Rm. 103 |
| Interventional Stroke Prevention: Close or Not to Close |
| Chairperson(s) | 임도선, 고영국 |
| Panel | 김중선, 박재형, 이봉기, 최윤석 |
|
All PFO Should Be Closed If Patient Experienced Stroke |
| 14:30-14:42 |
Pros
|
박재형 / 고려의대 |
| 14:42-14:54 |
Cons
|
박경우 / 서울의대 |
| 14:54-15:15 |
Discussion and Vote |
|
LAA Closure Should Be Performed in All AF Patients Experienced Stroke or Bleeding |
| 15:15-15:27 |
Pros
|
김중선 / 연세의대 |
| 15:27-15:39 |
Cons
|
배장환 / 충북의대 |
| 15:39-16:00 |
Discussion and Vote |
|
[KSIC 2] |
July 3(Fri.) 16:10-17:40 Rm. 103 |
| Gender-Based Issues in Interventional Cardiology |
| Chairperson(s) | 채인호, 안영근 |
| Panel | 김명아, 이봉기, 이상엽, 최석원, 홍지연 |
| 16:10-16:25 |
Fact Check!: Higher CVD Mortality in Women
|
김미나 / 고려의대 |
| 16:25-16:40 |
Assessment of Gender Differences in Plaque Morphology by CCTA
|
신상훈 / 이화의대 |
| 16:40-16:55 |
Possible Mechanism Showing the Gender Difference in Ischemic Heart Disease
|
김송이 / 제주의대 |
| 16:55-17:40 |
Discussion |
|
[KSIC 3] |
July 4(Sat.) 09:00-10:30 Rm. 103 |
| K-TAVI 2nd Cohort 결과 발표/토론회 |
| Chairperson(s) | 김효수, 박종선 |
| Panel | 김준홍, 유철웅, 윤영원, 이재환 |
| 09:00-09:10 |
K-TAVI Overview
|
김주한 / 전남의대 |
| 09:10-09:20 |
Small Annulus / Non- small Annulus - FEATURE & OUTCOME
|
채인호 / 서울의대 |
| 09:20-09:30 |
Annulus Area and Favorable 1 Year Survival in Women after TAVA: K-TAVI Registry
|
장기육 / 가톨릭의대 |
| 09:30-09:40 |
AF / Non AF - FEATURE & OUTCOME
|
최승혁 / 성균관의대 |
| 09:40-09:50 |
Risk Group: High/Intermediate/Low Surgical Risk - FEATURE & OUTCOME
|
김원장 / 차의대 |
| 09:50-10:00 |
75세 미만, 이상 - FEATURE & OUTCOME
|
최영진 / 세종병원 |
| 10:00-10:10 |
Optimal Over-Sizing Index for Each Valve - FEATURE & OUTCOME
|
강지훈 / 서울의대 |
| 10:10-10:30 |
Discussion |
|
[KSIC 4] |
July 4(Sat.) 13:10-14:40 Rm. 103 |
| Issues of Thrombocardiology 2020 |
| Chairperson(s) | 김무현, 한규록 |
| Panel | 김병극, 문재연, 정영훈, 조정래, 한주용 |
| 13:10-13:25 |
How to Select Optimal Candidates for Aspirin Use in Primary Prevention?
|
이종영 / 성균관의대 |
| 13:25-13:40 |
How to Select Optimal Candidates for Potent P2Y12 Inhibitor Use in Korean Patients with ACS?
|
유상용 / 울산의대 |
| 13:40-13:55 |
How to Select Optimal Candidates for Long-term Use of P2Y12 Inhibitor vs. NOAC in High-risk CAD Patients?
|
안종화 / 경상의대 |
| 13:55-14:10 |
High-bleeding Risk (HBR) Criteria: Validation, Clinical Application and Bleeding Avoidance Strategy
|
서정원 / 서울의대 |
| 14:10-14:40 |
Discussion |
|
[KSIC 5] |
July 4(Sat.) 14:50-16:20 Rm. 103 |
| The Role of Cardiovascular Imaging in CAD Patients |
| Chairperson(s) | 안태훈, 정명호 |
| Panel | 김성은, 박근호, 이진배, 최철웅 |
| 14:50-15:05 |
Can CT Angio Replace the CAG in Diagnosis of CAD?
|
장혁재 / 연세의대 |
| 15:05-15:20 |
The Role of Cardiac MR in CAD Patients
|
황성호 / 고려의대 |
| 15:20-15:35 |
The Merits and Demerits of IVUS for Coronary Intervention
|
김용철 / 연세의대 |
| 15:35-15:50 |
The Merits and Demerits of OCT for Coronary Intervention
|
조진만 / 경희의대 |
| 15:50-16:20 |
Discussion |
대한심장학회
대한부정맥학회
대한소아심장학회
대한심부전학회
대한심혈관중재학회
심장대사증후군학회
한국심초음파학회
한국지질·동맥경화학회